Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

Amgen’s next-generation cholesterol drug has shown it can reverse the build up of plaque build-up in coronary arteries which can lead to a heart attack or stroke. The company’s Repatha ...

However, revenues from key older medicines like Prolia, Repatha, Blincyto and new drugs like Tavneos and Tezspire are driving the top line. Amgen is also evaluating Prolia/Xgeva, Repatha ...

Amgen’s second-quarter results were strong ... Twelve products, including Prolia, Repatha, Blincyto, Tezspire and Evenity, achieved double-digit volume growth in the quarter.

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

Amgen had multiple drugs that grew at rates of more than 20%, including cholesterol drug Repatha, whose sales totaled $532 million and were up 25% year over year. Given the company's broad ...

Repatha (reducing cholesterol), Aimovig (migraine ... indications (such as chronic obstructive pulmonary disease). Amgen Inc. (NASDAQ:AMGN) increased its projection for FY 2024 operating EPS ...